Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
1.910
-0.170 (-8.17%)
Sep 6, 2024, 4:00 PM EDT - Market closed
Verrica Pharmaceuticals Stock Forecast
VRCA's stock price has decreased by -56.09% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for VRCA stock have an average target of 12.25, with a low estimate of 10 and a high estimate of 14. The average target predicts an increase of 541.36% from the current stock price of 1.91.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VRCA stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +580.63% | Aug 15, 2024 |
| Needham | Needham | Strong Buy Maintains $16 → $12 | Strong Buy | Maintains | $16 → $12 | +528.27% | Aug 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +737.70% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +632.98% | May 14, 2024 |
| Needham | Needham | Strong Buy Maintains $8 → $16 | Strong Buy | Maintains | $8 → $16 | +737.70% | May 14, 2024 |
Financial Forecast
Revenue This Year
24.08M
from 5.12M
Increased by 369.96%
Revenue Next Year
68.63M
from 24.08M
Increased by 185.01%
EPS This Year
-1.52
from -1.48
EPS Next Year
-0.98
from -1.52
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 29.5M | 99.8M | 204.8M | ||
| Avg | 24.1M | 68.6M | 139.5M | ||
| Low | 19.4M | 39.6M | 60.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 476.4% | 314.2% | 198.3% | ||
| Avg | 370.0% | 185.0% | 103.2% | ||
| Low | 278.7% | 64.4% | -11.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.43 | -0.60 | 0.43 | ||
| Avg | -1.52 | -0.98 | -0.29 | ||
| Low | -1.61 | -1.45 | -1.20 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.